Lasers in photodynamic therapy

Lasers in Medicine

Volumn , Issue , 2001, Pages 287-324

  Marcus, Stuart L ^a  

^a DUSA Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885009399     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (160)

1. C.J. Gomer, Photodynamic therapy in the treatment of malignancies, Seminars in Hematology 26, 27-34, (1989).
2. T.J. Dougherty and S.L. Marcus, Photodynamic Therapy, Eur. J. Cancer 28A, 1734-1742 (1992).
3. S.L. Marcus, Photodynamic therapy of human cancer, Proc. IEEE, 80, 869-889 (1992).
4. B.W. Henderson, Probing the effects of photodynamic therapy through in vivo-in vitro methods, in Photodynamic Therapy of Neoplastic Disease, D. Kessel (Ed.), Boca Raton, FL., CRC Press, pp. 169-188 (1990).
5. P.J. Bugelski, C.W. Porter and T.J. Dougherty. Autoradiographic distribution of hematoporphyrin in normal and tumor tissue of the mouse, Cancer Res, 41, 4606-4610, (1981).
6. C. Zhou, New trends in photobiology (invited review): mechanisms of tumor necrosis induced by photodynamic therapy, J. Photochem. Photobiol. 3, 299-318, (1989).
7. T.J. Wieman et al., Effect of photodynamic therapy on blood flow in normal and tumor blood vessels, Surgery 104, 512-517, (1988).
8. V.H. Fingar, T.J. Wieman and K.W. Dunk, Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction, Cancer Res., 50, 2599-2603, (1990).
9. D.R. Doiron et al., Fluorescence bronchoscopy for detection of lung cancer, Chest 76, 27-32, (1979).
10. A.E. Profio, Fluorescence diagnosis and dosimetry using porphyrins, in Photodynamic Therapy of Neoplastic Disease, D. Kessel (Ed.), Boca Raton, FL, CRC Press, pp. 77-90, (1990).
11. N.D. Ainsworth and J.A. Piper, Laser systems for photodynamic therapy, in Phototherapy of Cancer, G. Morstyn and A.H. Kayo (Eds.), New York, Harwood Academic Publishers, pp. 37-72, (1990).
12. U. Nseyo, R.K. Whalen and S. Lundahl, Photodynamic therapy in the management of bladder cancer, a critical review, Las. Inst. Amer. 64 ICALEO, 57-65, (1988).
13. R.C. Benson, Jr. Hematoporphyrin photodynamic therapy for transitional cell carcinoma of the bladder-an update, in Methods in Porphyrin Photosensitization, D. Kessel (Ed.), New York, Plenum Press, pp 3-12, (1985).
14. R.C. Benson, Jr. Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy, J. Urol. 134, 675-678, (1985).
15. X.W. Ha et al., Clinical use of hematoporphyrin derivative in malignant tumors. Chin. Med. J. 96, 754-758, (1983).
16. H. Hisazumi, T. Misaki and N. Miyoshi, Photodynamic therapy of bladder tumors, in Lasers and Hematoporphyrin Derivative in Cancer, Y. Hayata and T.J. Dougherty (Eds.), Tokyo, Igaku-Shoin, pp. 85-87, (1983).
17. H. Hisazumi, T. Misaki and N. Miyoshi, Photoradiation therapy of bladder tumors, J. Urol. 130, 685-687, (1983).
18. U.O. Nseyo and T.J. Dougherty, Photodynamic therapy in the management of resistant bladder cancer (abstract) Lasers Surg. Med. 6, 228, (1986).
19. B.P. Shumaker and F.W. Hetzel Clinical Laser photodynamic therapy in the treatment of bladder carcinoma, Photochem. Photobiol. 46, 899-901, (1987).
20. A. Tsuchiya, et al., Hematoporphyrin derivative and laser photo-radiation in the diagnosis and treatment of bladder cancer, J. Urol. 130, 79-82, (1983).
21. U.O. Nseyo, T.J. Dougherty and L. Sullivan, Evaluation of photodynamic therapy in the management of bladder cancer, Lasers Surg. Med. 7, 107, (1987).
22. U.O. Nseyo, T.J. Dougherty and L.L. Sullivan, Photodynamic therapy in the management of resistant lower urinary tract carcinoma, Cancer 60, 3113-3119, (1987).
23. G.R. Prout Jr., P. Griffin and J.J. Daly, The outcome of conservative treatment of carcinoma in situ of the bladder, J. Urol. 138, 766-770, (1987).
24. G.R. Prout Jr. et al., Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional call carcinoma of the bladder, N. Engl. J. Med. 317, 1251-1255, (1987).
25. J.I. Harty et al., Complications of whole bladder dihematoporphyrin ether photodynamic therapy, J. Urol. 141, 1341-1346, (1989).
26. M. Dugan et al., A randomized trial of observation (OBS) vs. photodynamic therapy (PDT) after transurethral resection (TUR) for superficial papillary bladder carcinoma (SPBC), Proc. Ann. Mtg. Am. Soc. Clin. Onc., 10, 554, (1991).
27. J.P.A. Marynissen, H. Jansen and W.M. Star, Treatment system for whole bladder wall photodynamic therapy with in vivo monitoring and control of light dose rate and dose, J. Urol. 142, 1351-1355, (1989).
28. U.O. Nseyo, S.L. Lundahl and D.C. Merrill, Whole bladder photodynamic therapy: critical review of present-day technology and rationale for development of intravesical laser catheter and monitoring system, Urology 36, pp. 398-402, (1990).
29. M.M. Walther, The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer. Urologic Clin. N. Am. 27, 163-170 (2000).
30. U. Nseyo et al., Urinary cytokines following photodynamic therapy for bladder cancer, Urology 36, 167-171, (1990).
31. D.A. Cortese and J.H. Kinsey, Bronchoscopic phototherapy using hematoporphyrin derivative, Surg. Clin. N. Am. 64, 941-946, (1984).
32. D.A. Cortese and J.H. Kinsey, Hematoporphyrin derivative phototherapy in the treatment of brochogenic carcinoma, Chest 86, 8-13, (1984).
33. E.S. Edell and D.A. Cortese, Bronchogenic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: A 5-year experience, Mayo Clin. Proc. 62, 8-14, (1987).
34. Y. Hayata et al., Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer, Chest 86, 169-177, (1984).
35. Y. Hayata et al., Photoradiation therapy in early stage cancer cases of the lung, esophagus and stomach, in Porphyrins in Tumor Phototherapy, A. Andreoni and R. Cubeddu (Eds.), New York, Plenum Press, pp 405-412, (1984).
36. Y. Hayata et al., Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 81, 269-277, (1982).
37. H. Kato, C. Konaka and J. Ono, Effectiveness of HPD and radiation therapy in lung cancer, in Methods in Porphyrin Photosensitization, D. Kessel, and T.J. Dougherty (Eds.), New York, Plenum Press, pp 23-39 (1983).
38. H. Kato, Lung cancer, in Lasers and Hematoporphyrin Derivative in Cancer, Y. Hayata and T.J. Dougherty (Eds.), Tokyo, Igaku-Shoin, pp 39-56, (1983).
39. G.S. Keller, D.R. Doiron and G.U. Fisher, Photodynamic therapy in otolaryngology -head and neck surgery, Arch. Otolaryngol. 111, 758-761, (1985).
40. J.H. Li, Y.P. Chen and S.D. Zhao, Application of hematoporphyrin derivative and laser-induced photodynamical reaction in the treatment of lung cancer: A preliminary report of 21 cases, Lasers Surg. Med. 4, 31-37, (1984).
41. R.G. Vincent et al., Photoradiation therapy in advanced carcinoma of the trachea and bronchus, Chest 85, 29-33, (1984).
42. R. Vincent and T.J. Dougherty, Photoradiation therapy in the treatment of advanced carcinoma of the trachea and bronchus, in Porphyrin Localization and Treatment of Tumors, D.R. Doiron and C.J. Gomer (Eds.), New York, Alan R Liss Inc, pp. 759-766, (1984).
43. S. Karanov et al., Photodynamic therapy in lung and gastrointestinal cancers, J. Photochem. Photobiol., B: Biology, 6, 175-181, (1990).
44. O.J. Balchum, D.R. Doiron, Photoradiation therapy of endobronchial lung cancer: large obstructing tumors, nonobstructing tumors, and early-stage bronchial cancer lesions, Clin. Chest Med. 6, 255-275, (1985).
45. J.S. McCaughan Jr, T.E. Williams and B.H. Bethel, Photodynamic therapy of endobronchial tumors, Lasers Surg. Med. 6, 336-345, (1986).
46. P. Hugh-Jones and W.N. Gardner, Laser photodynamic therapy for inoperable bronchogenic squamous carcinoma, Quart. J. Med. 64, 565-582, (1987).
47. H. Kato et al., Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy, Chest 90, 768-770, (1986).
48. J.S. Nelson, R.D. Fairshter and M.W. Berns, Long-term survival of a lung cancer patient treated with photodynamic therapy. Case Report, Lasers in Surg. & Med. 10, 208-210, (1990).
49. H. Kato et al., Preoperative laser photodynamic therapy in combination with operation in lung cancer, J. Thorac. Cardiovasc. Surg. 90, 420-429, (1985).
50. S. Lam et al., A randomized comparative study of the safety and efficacy of photodynamic therapy using PHOTOFRIN II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma, Photochem. Photobiol., 46, 893-897, (1987).
51. H.I. Pass et al., Bronchoscopic phototherapy at comparable dose rates: early results, Ann. Thoracic Surg. 47, 693-699, (1989).
52. J. LoCicero, M. Metzdorff and C. Almgren, Photodynamic therapy in the palliation of late-stage obstructing non-small-cell lung cancer, Chest 98, 97-100, (1990).
53. PHOTOFRIN (Porfimer sodium) package insert (approved labeling), Axcan Scandipharm, Inc. (2000).
54. P.A. Cowled, L. Mackenzie and I.J. Forbes, Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids, Cancer Lett. 29, 107-114, (1985).
55. J.M. Budinger, Untreated bronchogenic carcinoma, Cancer 11, 106-116, (1958).
56. L. Corti et al., Photodynamic therapy in gynecological cancer, Lasers Med. Sci. 4, 155-158, (1989).
57. I.J. Forbes et al., Phototherapy of human tumors using haematoporphyrin derivative, Med J. Aust. 2, 489-493, (1980).
58. A. Dahlman et al., Laser photoradiation therapy of cancer, Cancer Res, 43, 430-434, (1983).
59. J. Kennedy, HPD photoradiation therapy for cancer at Kingston and Hamilton, in Porphyrin Photosensitization, D. Kessel and T.J. Dougherty (Eds.), New York, Plenum Press, pp 53-62, (1983).
60. S.B. Lele et al., Photodynamic therapy in gynecologic malignancies, Gynecolog. Oncol. 34, 350-352, (1989).
61. R.V. Lobraico et al., Photodynamic therapy for cancer of the lower female genital tract, Colposcopy Gynecol. Laser Surg. 2, 185-199, (1986).
62. J.S. McCaughan Jr. et al., Photodynamic therapy of gynecologic neoplasms after presensitization with hematoporphyrin derivative, Lasers Surg. Med. 5, 491-498, (1985).
63. M.A. Rettenmaier et al., Gynecologic uses of photoradiation therapy, in Porphyrin Localization and Treatment of Tumors, D.R. Doiron and C.J. Gomer (Eds.), New York, Alan R Liss Inc., pp. 767-775, (1984).
64. H. Soma and S. Nutahara, Cancer of the female genitalia, in Lasers and Hematoporphyrin Derivative in Cancer, Y. Hayata and T.J. Dougherty (Eds.), Tokyo, Igaku-Shoin, pp 97-109 (1983).
65. B.G. Ward et al., The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment, Am. J. Obstet. Gynecol. 112, 356-357, (1982).
66. J.S. McCaughan, Jr., Photoradiation of malignant tumors presensitized with hematoporphyrin derivative, in Porphyrin Localization and Treatment of Tumors, D.R. Doiron and C.J. Gomer (Eds.), New York, Alan R Liss Inc, pp. 805-827, (1984).
67. W.M. Cai et al. Photodynamic therapy in the management of cancer: An analysis of 114 cases, in Methods in Porphyrin Photosensitization, Kessel (Ed.), New York, Plenum Press, pp 13-19, (1985).
68. J.A.S. Carruth and A.L. McKenzie, Preliminary report of a pilot study of photoradiation therapy for the treatment of superficial malignancies of the skin, head and neck, Eur. J. Surg. Oncol. 11, 47-50, (1985).
69. L.I. Grossweiner, J.H. Hill and R.V. Lobraico, Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial, Photochem. Photobiol. 46, 911-917, (1987).
70. O.E. Schuller, J.S. McCaughan, Jr., R.P. Rock, Photodynamic therapy in head and neck cancer, Arch. Otolaryngol. Vol. 111, pp. 351-355, (1985).
71. C. Taketa and M. Imakiire, Cancer of the ear, nose, and throat, in Lasers and Hemtoporphyrin Derivative in Cancer, Y. Hayata and T.J. Dougherty (Eds.), Tokyo, Igaku-Shoin, pp. 70-78, (1983).
72. A.G. Wile et al., Photoradiation therapy of head and neck cancer, in Porphyrin Localization and Treatment of Tumors, C.J. Gomer and D.R. Doiron (Eds.), New York, Alan R Liss Inc, pp. 681-691, (1984).
73. F.Y. Zhao et al., Use of haematoporphyin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumors: A preliminary report, Lasers Med. Sci. 1, 253-256, (1986).
74. F.Y. Zhao et al., Treatment of 510 cases of oral squamous cell carcinoma, Am. Acad. Med. 18, Singapore 533-536, (1989).
75. V.G. Schweitzer, Photodynamic therapy for treatment of head and neck cancer, Otolaryngol. Head Neck Surg. 102, 225-232, (1990).
76. V.G. Schweitzer and D. Visscher, Photodynamic therapy for treatment of AIDS-related oral Kaposi’s sarcoma. Otolaryngol. Head Neck Surg. 102, 639-649, (1990).
77. C. Freche and S. DeCorbiere, Use of photodynamic therapy in the treatment of vocal cord carcinoma, J. Photochem. Photobiol. 6, 291-296, (1990).
78. J.L. Gluckman, Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience, Laryngoscope 101, 36-42, (1991).
79. B.L. Wenig et al., Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck, Arch. Otolaryngol. Head Neck Surg. 116, 1267-1270, (1990).
80. M.A. Biel, Photodynamic therapy and the treatment of head and neck cancer, The Laryngoscope 108, 1259-1268 (1998).
81. A.G. Wile et al., Laser photoradiation therapy of cancer: an update of the experience at the University of California, Irvine, Lasers Surg. Med. 4, 5-12, (1984).
82. M.E. Tian, S.L. Qui and Q. Ji, Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of early esophageal carcinoma, Adv. Exp. Med. Biol. 193, 21-25, (1985).
83. M. Fujimaki and K. Nakayama, Endoscopic laser treatment of superficial esophageal cancer, Semin. Surg. Oncol. 2, 248-256, (1986).
84. F. Calzavara et al., Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy, J. Photochem. Photobiol, B:Biology, 6, 167-174, (1990).
85. P. Monnier et al., Photodetection and photodynamic therapy of “early” squamous cell carcinoma of the pharynx, esophagus and tracheobronchial tree. Lasers Med. Sci. 5, 149-169, (1990).
86. R.J. Thomas et al., High-dose photoradiation of esophageal cancer, Ann. Surg. 206, 193-199, (1987).
87. J.S. McCaughan Jr., T.A. Nims and J.T. Guy, Photodynamic therapy for esophageal tumors, Arch. Surg. 124, 74-80, (1989).
88. A. Segalin et al., Surgical and endoscopic palliation of esophageal carcinoma, Ann. Thoracic Surg. 48, 267-271, (1989).
89. T. Patrice et al., Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients, Digestive Dis. & Sci. 35, 545-552, (1990).
90. H.M. Likier, J.G. Levine and C. Lightdale, Photodynamic therapy for completely obstructing esophageal carcinoma, Gastro. Endosc. 37, 75-78, (1991).
91. M. Dal Fante, G. Bottiroli, and P. Spinelli, Behavior of hematoporphyrin derivative in adenomas and adenocarcinomas of the colon: a microfluorometric study, Lasers Med. Sci., 3, 165-171, (1988).
92. R.C. Haggitt, Barrett’s esophagus, dysplasia, and adenocarcinoma, Hum. Pathol. 25, 982-993 (1994).
93. N. Barrett, Chronic peptic ulcer of the oesophagus and oesophagitis. Br. J. Surg. 38, 175-182 (1950).
94. S.S. Devesa, W.J. Blot, J.F. Fraumeni Jr., Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83(10), 2049-53, (1998).
95. P. Gillen et al., Experimental columnar metaplasia in the canine oesophagus, Br. J. Surg. 75, 113-5, (1988).
96. G.W. Falk, Reflux disease and Barrett’s esophagus, Endoscopy, 31(1), 9-16, (1999).
97. W.A. Williamson et al., Barrett’s oesophagus. prevalence and incidence of adenocarcinoma, Arch. Int. Med. 151, 2212-2216, (1991).
98. M. Miros, P. Kerlin, N. Walker, Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus, Gut 32(12), 1441-6, (1991).
99. A.J. Cameron et al., Prevalence of columnar lined Barrett’s oesophagus: comparison of population based clinical and autopsy findings. Gastroenterology 99, 918-922, (1990).
100. C. Winters et al., Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease, Gastroenterology 92, 118-124, (1987).
101. R.W. Sjogren, L.F. Johnson, Barrett’s esophagus: a review, Am. J. Med. 74, 313-21, (1983).
102. W. Hameeteman et al., Barrett’s esophagus: development of dysplasia and adenocarcinoma, Gastroenterology 96(5), 1249-56, (1989).
103. A.J. Cameron, B.J. Ott, W.S. Payne, The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus, N. Engl. J. Med. 313(14), 857-9, (1985).
104. D.J. Drewitz, R.E. Sampliner, H.S. Garewal, The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years, Am. J. Gastro. 92(2), 212-5, (1997).
105. A.P. Burke et al., Dysplasia of the stomach and Barrett’s oesophagus: a follow-up study, Modern Pathol. 4, 336-41, (1991).
106. B.F. Overholt, M. Panjehpour, J.M. Haydek, Photodynamic therapy for Barrett’s esophagus: followup in 100 patients, Gastro. Endosc. 49, 1-7, (1999).
107. H. Barr et al., The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon, Br. J. Cancer 62, 730-735, (1990).
108. H. Barr et al., Photodynamic therapy for colorectal cancer: a quantitative pilot study, Br. J. Surg. 71, 93-96, (1990).
109. M. Aida and M. Kawagulhi, Gastric cancer, in Lasers and Hematoporphyrin Derivative in Cancer Y. Hayata and T. Dougherty (Eds.). NY/Tokyo Igaka-Shoin, pp. 65-69, (1983).
110. Y. Hayata et al., Photodynamic therapy with hematoporphyrin in cancer of the upper gastrointestinal tract, Seminars Surg Onc. 1, 1-11, (1985).
111. S. Okuda et al., Experimental and clinical studies on HPO-photoradiation therapy for upper gastrointestinal cancer, in Porphyrins in Tumor Phototherapy, Adreoni, A. and Cubedda, R. (Eds.), NY/London, Plenum Press, pp. 413-421, (1984).
112. H. Tajiri et al., Photoradiation in early gastrointestinal cancer, Gastro. Endosc. 33, 88-90, (1987).
113. T. Nakamura et al., Photodynamic therapy for early gastric cancer using a pulsed gold vapor laser, J. Clin. Laser Surg. (Oct.), 63-67, (1990).
114. P.J. Muller, and B.C. Wilson, Photodynamic therapy of malignant brain tumors: clinical effects, postoperative ICP, and light penetration of the brain, Photochem. Photobiol. 46, 929-935, (1987).
115. R.N. Nambisan et al., Intraoperative photodynamic therapy for retroperitoneal sarcomas, Cancer 61, 1248-1252, (1988).
116. J.S. McCaughan Jr. et al., Photodynamic therapy to treat tumors of the extrahepatic biliary ducts, Arch. Surg. 126, 111-113, (1991).
117. W.F. Sindelar et al., Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms: Phase I Study, Arch. Surg. 126, 318-324, (1991).
118. H. Pass et al., Intraoperative photodynamic therapy after resection of pleural malignancies, Abstract XX/5. 3rd Biennial Meeting, Int. Photodynam. Assoc., (1990).
119. L. Lofgren et al., Transthoracic endoscopic photodynamic treatment of malignant mesothelioma, Lancet 337, 359, (1991).
120. A.H. Kaye, and J.S. Hill, Photoradiation therapy of brain tumors: laboratory and clinical studies, in Phototherapy of Cancer, Morstyn, G. and Kaye, A. (Eds.), New York, Harwood Academic Publishers, pp. 101-118, (1990).
121. P.J. Muller and B.C. Wilson, Photodynamic therapy for recurrent supratentorial gliomas, Semin. Surg. Oncol. 11, 346-354 (1998)
122. C. Perria et al., First attempts at the photodynamic treatment of human gliomas, J. Neurosurg. 24, 119-129, (1980).
123. E.R. Laws et al., Photoradiation therapy in the treatment of malignant brain tumors: a Phase I (feasibility) study, Neurosurg. 9, 672-678, (1981).
124. G.A.J. McCullough et al., Phototherapy in malignant brain tumors, in Porphyrin Localization and Treatment of Tumors, D.R. Doiron and C.J. Gomer (Eds.), New York, Alan R Liss Inc, pp. 709-717, (1984).
125. P.J. Muller and B.C. Wilson, Photodynamic therapy of malignant brain tumors, Lasers Med. Sci. 5, 245-251, (1990).
126. H. Kostron, E. Fritsch and V. Grunert, Photodynamic therapy of malignant tumors: a phase I/II trial, Br. J. Neurosurg. 2, 241-248, (1988).
127. S.K. Powers et al., Stereotaxic intratumoral photodynamic therapy of recurrent malignant brain tumors, Neurosurgery 29, 688-695 (1991).
128. C. Perria, G. Casu and E. Sgaramella, Proposal of a protocol for the photodynamic therapy of malignant brain tumors, Photochem. Photobiol. 6, 443-445, (1990).
129. D.T. Tse, R.C. Kersten and R.L. Anderson, Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. Preliminary report, Arch. Ophthalmol. 102, 990-994, (1984).
130. D.T. Tse et al., Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma, Ophthalmology 102, 833-838, (1984).
131. T.W. Sery et al., Photodynamic therapy of human ocular cancer, Ophthalmic Surg. 18, 413-418, (1987).
132. A.L. Murphree, M. Cote and C.J. Gomer, The evolution of photodynamic therapy techniques in the treatment of intraocular tumors, Photochem. Photobiol. 46, 919-923 (1987).
133. R.A. Bruce and J.S. McCaughan, Lasers in uveal melanoma. Ophthalmol. Clin. N. Am. 2, 597-604, (1989).
134. Y. Ohnishi, Y. Yamana and M. Minei, Photoradiation therapy using argon laser and a hematoporphyrin derivative for retinblastoma: a preliminary report, Jpn. J. Ophthalmol. 30, 409-419, (1986).
135. C. Bandieramonte et al., Laser phototherapy following HpD administration in superficial neoplastic lesions, Tumori 70, 327-334, (1984).
136. D. Gilson et al., Therapeutic ratio of photodynamic therapy in the treatment of superficial tumors of skin and subcutaneous tissues in man, Br. J. Cancer 58, 665-667, (1988).
137. J.S. McCaughan Jr. et al., Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms, Arch. Surg. 124, 211-216, (1989).
138. D.J. Pennington, M. Waner and A. Knox, Photodynamic therapy for multiple skin cancers, Plastic & Reconst. Surg. 82, 1067-1071, (1987).
139. P.J. Robinson, J.A.S. Carruth, and G.M. Fairris, Photodynamic therapy: a better treatment for widespread Bowen’s disease, Br. J. Derm. 199, 59461, (1988).
140. M. Schuh et al., Photodynamic therapy for palliation of locally recurrent breast carcinoma, J. Clin. Onc. 5, 1766-1770, (1987).
141. S.N. Waldow et al., Photodynamic therapy for treatment of malignant cutaneous lesions, Lasers Surg. Med. 7, 451-456, (1987).
142. B.W. Wilson et al., Use of photodynamic therapy for the treatment of extensive basal cell carcinomas, Facial Plast. Surg. 6, 185-189, (1990).
143. P.W. Sperduto et al., Photodynamic therapy for chest wall recurrence in breast cancer, Int J. Radiation Oncol. Bio. Phys. 21, 441-446, (1991).
144. D. Kessel, In vitro photosensitization with a benzoporphyrin derivative. Photochem. Photobiol. 49, 579-582 (1989).
145. H. Lui et al. Photodynamic therapy of malignant skin tumors with benzoporphyrin derivative monoacid ring A (BPD-MA). Proc. Am. Soc. Photobiol. (Meeting Abstract), in press (1993).
146. S.L. Fine et al., Age-related macular degeneration, N. Eng. J. Med. 342, 483-492 (2000)
147. VISUDYNE (Verteporfin for Injection) Package Insert (Approved Labeling), QLT Inc. and CIBA Vision, Inc. (2000).
148. J.C. Kennedy and R. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol 14, 275-292 (1992).
149. P. Wolf, E. Rieger and H. Kerl, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28, 17-21, (1993).
150. S.D. Shanler et al., Localization of endogenous protoporphyrin IX and effects of photodynamic therapy in human and murine carcinomas. Proc. Am. Assoc. Cancer Res. Abstract #2161, 34, 363 (1993).
151. LEVULAN KERASTICK Package Insert (Approved Labeling), DUSA Pharmaceuticals, Inc. and Schering, AG/Berlex Laboratories (2000).
152. J. Bedwell et al., Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br. J. Cancer 65, 818-824 (1992).
153. C.S. Loh et al., Photodynamic therapy of the normal rat stomach: A comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolevulinic acid. Br. J. Cancer 66, 452-462 (1992).
154. L. Gossner et al., Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology, 1998; 114:448-55.
155. R. Ackroyd et al., Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomized, placebo controlled trial. Gut. 2000; 47:612-7
156. S.L. Marcus et al., Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Current clinical and development status. J. Clin. Laser Med. Surg. 1996;14:59-66.
157. R. Ackroyd et al., 5-Aminolevulinic acid photosensitization of dysplastic Barrett’s esophagus: a pharmacokinetic study. Photochem. Photobiol. 1999; 70:656-62.
158. C.J. Kelty et al., Photodynamic therapy for dysplastic Barrett’s oesophagus: Long term follow up. Br. J. Surg. 2001; 88:(in press).
159. H. Messman et al., Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitization in normal rat colon by threshold and light fractionation studies. Br J. Cancer 1995;72:589-94.
160. A. Curnow, J.C. Haller and S.G. Bown, Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J. Photochem. Photobiol. Biology 2000;58:149-155.